Leeds Unit for Complex Intervention Development (LUCID)
- Group summary: LUCID is a methodological research group based across LIHS and LICTR within the School of Medicine, developing and optimising complex healthcare interventions to improve patient and public outcomes.
- Website: https://twitter.com/lucid_leeds?lang=en-gb
Our mission
We provide an interdisciplinary centre of excellence for developing and optimising complex health care interventions. Using mixed-methods research, our aim is to develop evidence-based interventions designed to be implemented and tested in ‘real world’ applied health care settings, and to push forward the methodological approaches to intervention development and process evaluation. Our interventions will be designed to improve the outcomes for both service users and providers.
Rationale
In 2008 the Medical Research Council published a framework for developing and evaluating complex interventions (most recent update 2021). Complex interventions include a ‘black box’ of multiple, interacting components and mechanisms which are modified by the context in which the intervention is delivered. Understanding these factors is critical to ensuring a novel intervention is fit for purpose, can be reproduced/implemented elsewhere, and is likely to result in important health benefits whilst minimising unintended consequences.
What we do
We use mixed methods approaches, combining evidence synthesis, qualitative and quantitative methods, to deliver evidence-based intervention development and process evaluation. We work across a range of conditions (e.g. cancer, musculoskeletal disease, surgical specialties) and settings (e.g. acute care, primary care) with a shared characteristic that these interventions are, to varying degrees, complex in nature and require careful design to optimise their clinical and cost effectiveness when implemented real world settings.
Who we are
The diversity of methodological approaches applied in intervention development and process evaluation studies can appear daunting. Established in 2019, LUCID is a virtual network of researchers from diverse methodological backgrounds who are brought together by a shared academic interest. LUCID will create opportunities for: (1) high quality methodological research embedded within clinical research programmes; and (2) provide a platform for research groups in the School of Medicine and beyond to facilitate knowledge generation and transfer, as well as, sharing expertise regarding the evidence-based approaches to healthcare intervention development.
Read more about complex interventions research within the School of Medicine.
Prof Suzanne Richards, Head of LUCID
Email: Lucid@leeds.ac.uk
Twitter: @Lucid_leeds
Continuing Professional Development Courses
We run Continuing Professional Development training courses on a range of areas related to complex intervention development and optimisation. Our upcoming training courses include:
Introducing the multiphase optimisation strategy (MOST) and optimisation trials
Led by Professor Sam Smith and Dr Rebecca Walwyn.
This three-day in-person course provides an introduction to a new framework for optimising complex interventions to help build more effective, affordable, scalable and efficient interventions.
• Dates: 22 to 24 January 2025
• Cost: Early bird £425, then £525 (inclusive of tuition, lunch and refreshments)
• If you would like to reserve a place on this course, please email w.hobson@leeds.ac.uk.
Two-day process evaluation methods for applied health and postgraduate researchers
Led by Nikki Rousseau, Susanne Coleman, Matthew Mulvey, and Suzanne Richards.
Process evaluation methods seek to explain how health care interventions bring about changes in clinical outcomes, and are increasingly embedded within clinical trials. This two-day online course (spread across 2 weeks) provides expert training on how to conduct process evaluations in applied health research.
• Dates: Thursday 20 and Wednesday 26 March 2025
• Cost: Early bird £350 until 20 February, £400 after
• If you would like to reserve a place on the course, please use this booking link.
Seminar programme
We hold regular seminars related to complex intervention development and optimisation. To keep updated about our seminars, please join our mailing list by emailing LUCID@leeds.ac.uk.
External seminars
We aim to hold around three external seminars per year that anyone is welcome to attend.
Our next external seminars are:
• Thursday 30 January 2025, 11am – 12pm: Professor Susan Wong, University of Washington. ‘Unravelling the complexities of conservative kidney management to enhance care for patients with kidney failure who forgo dialysis’
• Wednesday 26 February 2025, 2pm – 3pm: Professor Maria Lonsdale, University of Leeds. ‘The power of information design in communicating healthcare information: Recover Together as a case study’
Our previous external seminars have included:
• Tuesday 27th February 2024, 10am – 11.30am: Dr Rebecca Barnes and Christopher Newby, NIHR Research Support Service (RSS) Hub delivered by the University of Leicester and partners; and Alicia Cantrell, NIHR Clinical Research Network Yorkshire and the Humber. ‘Embedding equality, diversity and inclusion in your funding applications and research’ (joint seminar with the NIHR Leeds Biomedical Research Centre)
• Wednesday 29th May 2024, 11am – 12pm: Professor Nick Hulbert-Williams, Edge Hill University. ‘All is not what it seems in psycho-oncology: why we might be targeting the wrong intervention outcomes, and how we might do things differently’
Internal seminars
We also hold additional internal seminars that are open to staff and postgraduates at the University of Leeds and Leeds-based health professionals. Our next internal seminar is:
- Wednesday 27th November 2024, 11am – 12pm: Ella Howes, University of Leeds. ‘Designing and reporting complex intervention using the Behaviour Change Intervention Ontology’
Our previous internal seminars have included:
• Wednesday 26th June 2024, 10am – 11am: Sadia Ahmed, Adam Galloway, University of Leeds. ‘Mixed methods approaches for evaluating complex intervention uptake’
• Wednesday 24th July 2024, 11am – 12pm: Sarah Cecilie Tscherning, Aarhus University, Denmark, and Laura McLarty, University of Leeds. 'Involving patient partners in research: challenges and opportunities'
Meet our team
Core LUCID Team members
Suzanne Richards (Head of Unit)
LUCID seminars and communications co-leads
Sadia Ahmed
Areas of Expertise
Our aim is to develop and apply complex interventions that can be implemented in real-world settings, and which improve health care and health outcomes. Our expertise is in applying appropriate study designs and methods to develop, optimise, and evaluate the processes of embedding complex interventions in applied health settings.
We are a mixture of applied health researchers and clinical trial methodologists, and we use a range of methods (including qualitative and quantitative study designs and health economic appraisal) to inform the content and implementation of complex interventions. We also undertake research to improve study methods and to inform the design and conduct of clinical trials.
Our experts in specific methods are listed are listed below:
Complex intervention development
The design, development, optimisation and testing of complex interventions within health and social care settings to support health care professionals, prevent ill health and improve patient outcomes. We apply a range of theoretical frameworks and approaches to support evidence-based intervention development in our specialist areas.
Methodological expertise: qualitative research; randomised trial design (including feasibility & pilot designs), survey research, systematic reviews
Specialist interest areas: cancer prevention and control; health behaviours; obesity & weight management
Methodological expertise: critical review methods; experimental and evaluation methods, qualitative methods, survey methods
Specialist interest areas: patient and professional decision support interventions for long-term conditions (kidney failure, multiple sclerosis), screening and testing procedures (cancer, genetic, prenatal)
Methodological expertise: consensus methods, instrument development and evaluation methods, cognitive pre-testing methods (focus groups, think out loud interviews), complex intervention development and evaluation methods, participatory research, realist evaluation
Specialist interest areas: skin wound care, pressure ulcer prevention, healthcare interventions for older people, frailty
Methodological expertise: participatory methods, qualitative methods
Specialist interest areas: antimicrobial resistance, community engagement, global health
Methodological expertise: feasibility & pilot trial design, intervention adaptation, patient reported outcome measures (PROMS), quantitative process evaluation, systematic reviews and meta-analysis
Specialist interest areas: advanced cancer and palliative care, quantitative symptoms assessment
Methodological expertise: consensus methods, observational study design, qualitative methods, randomised trial designs (feasibility, pilot & definitive trials), survey methods (including psychometrics), systematic reviews and meta-analysis
Specialist interest areas: health and social care interventions for older people, primary care, rehabilitation, multi-morbidity and frailty
Methodological expertise: qualitative methods, mixed methods
Specialist interest areas: Surgery, diagnostics and devices
Methodological expertise: survey research, co-design, systematic reviews, qualitative research, user-testing, randomised trial designs (including feasibility, pilot & optimisation trials), SWATs
Specialist interest areas: cancer prevention and control, health behaviours, medication adherence, weight management
Methodological expertise: patient reported outcome measure (PROM) development and validation, qualitative methods, systematic reviews
Specialist interest areas: advanced cancer and palliative care, advance care planning
Mixed-methods research and process evaluation
The use of mixed-methods process evaluation to build robust interventions that can be implemented in real-word settings. This approach provides an understanding of context, mechanism, acceptability, feasibility and fidelity of the complex interventions and how these affect health outcomes. Process evaluations also inform the design of clinical trial methods to maximise participant engagement.
Methodological expertise: consensus methods, instrument development and evaluation methods, cognitive pre-testing methods (focus groups, think out loud interviews), complex intervention development and evaluation methods, participatory research, realist evaluation
Specialist interest areas: skin wound care, pressure ulcer prevention, healthcare interventions for older people, frailty
Methodological expertise: participatory methods, qualitative methods
Specialist interest areas: antimicrobial resistance, community engagement, global health
Methodological expertise: consensus methods, observational study design, qualitative methods, randomised trial designs (feasibility, pilot & definitive trials), survey methods (including psychometrics), systematic reviews and meta-analysis
Specialist interest areas: health and social care interventions for older people, primary care, rehabilitation, multi-morbidity and frailty
Methodological expertise: qualitative methods, mixed methods
Specialist interest areas: Surgery, diagnostics and devices
Randomised trial design and evaluation
The development and application of randomised trials in early phase intervention development and optimisation, later phase pragmatic evaluation, and of methods to implement effective interventions, including both complex and efficient designs (including primary, secondary and routinely collected data). Further information on our trials evaluating complex interventions can be found here. We also work closely with the Acadmic Unit of Health Economics.
Methodological expertise: qualitative research; randomised trial design (including feasibility & pilot designs), survey research, systematic reviews
Specialist interest areas: cancer prevention and control; health behaviours; obesity & weight management
Methodological expertise: medical statistics, randomised trial designs (feasibility, pilot & definitive trials), SWATs
Specialist interest areas: health and social care for older people, primary care, stroke management
Methodological expertise: cluster randomised trial design, interrupted time series design
Specialist interest areas: implementation science, primary care
Methodological expertise: health economic evaluation; experimental and quasi-experimental evaluation methods; applied econometric methods; observational data analysis
Specialist interest areas: public health, diet, physical activity, cancer, obesity, dementia
Methodological expertise: consensus methods, observational study design, qualitative methods, randomised trial designs (feasibility, pilot & definitive trials), survey methods (including psychometrics), systematic reviews and meta-analysis
Specialist interest areas: health and social care interventions for older people, primary care, rehabilitation, multi-morbidity and frailty
Methodological expertise: survey research, co-design, systematic reviews, qualitative research, user-testing, randomised trial designs (feasibility, pilot & optimisation trials), SWATs
Specialist interest areas: cancer prevention and control, health behaviours, medication adherence, weight management
Methodological expertise: medical statistics, randomised trial designs (feasibility, pilot, optimisation & definitive trials), using Design of Experiments applied to health and social care, SWATs, systematic reviews and meta-analysis
Specialist interest areas: mental health including dementia, implementation science
Academic capacity development
LUCID offers a vibrant, supportive environment in which to undertake a higher research degree in the field of complex intervention development. We also support and mentor researchers looking to build/consolidate their skills as part of post-doctoral training awards working with colleagues from the wider School of Medicine and external partnerships with other Universities.
We work flexibly offering both full-time and part-time registration; many of our higher degree candidates combine study with clinical practice. If you would like to find out more about supervision opportunities, please do contact us to discuss your interests.
PhD candidates and capacity building fellowships
Current PhD candidates supervised by LUCID academics:
Anas Almatrafi – Saudi Arabian Cultural Bureau and Ministry of Education studentship (2020-24) with Rebecca Beeken
Aarthi Bhuvaraghan – Doctoral researcher (2020-26) with Rebecca King
Louise Englebrecht Buur (Aarhus University) – (2020-24) with Hilary Bekker
Adam Galloway – NIHR/HEE (ICA) Clinical Doctoral Fellowship (2021-25) with Suzanne Richards
Adam Grice – NIHR Clinical Doctoral Fellowship (2023-2028) with Robbie Foy, Suzanne Richards and Rebecca Beeken
Zainab Haider – ESRC WRDTP Advanced Quantitative Methods (1+3) (2021-25) with Sam Smith, Rebecca Beeken, and Rebecca Walwyn
Fern Harvey – NIHR Yorkshire and Humber ARC Studentship (2023-26) with Robbie Foy, Amanda Farrin, and Suzanne Richards
Ella Howes – MRC-NIHR Trials Methodology Research Partnership doctoral studentship (2023-2026) with Amanda Farrin and Sam Smith
Catherine Malia – St Gemma’s Hospice (2021-25) with Lucy Ziegler
Yousuf Mokhallalati - Yorkshire Cancer Research (2018-24) with Lucy Ziegler
Anders Lerche Møller (Aarhus University) (2024-27) with Rebecca Beeken
Delia Muir - with Susanne Coleman (2022- 2026)
Jessica Pearce – NIHR Doctoral Fellowship (2022-25) with Suzanne Richards
Louise Savic – NIHR Doctoral Fellowship (2021-24) with Nikki Rousseau
Nicola Shaw – NIHR/HEE (ICA) Clinical Doctoral Fellowship (2021-25) with Nikki Rousseau
Leanne Shearsmith- NIHR Doctoral Fellowship (2024-2027) with Rebecca Beeken
Anna Taylor – NIHR Patient Safety Research Collaboration (2024-27) with Robbie Foy, Suzanne Richards and Anna Anderson
Janet Tonge – University of Leeds Scholarship (2018-24) with Hilary Bekker
Hannah Truscott – University of Leeds Studentship (supported by Yorkshire Cancer Research Fellowship awarded to Dr Beeken) (2023-2028) with Rebecca Beeken
Sean White (University of Sheffield) – NIHR Doctoral Fellowship (2021-24) with Hilary Bekker (Leads A O’Caithain and C McDermott, Sheffield)
Recently completed PhD candidates supervised by LUCID academics:
Sadia Ahmed – MRC-NIHR Trials Methodology Research Partnership doctoral studentship (2019-24) with Amanda Farrin and Suzanne Richards
Amy Barradell (University of Leicester) – NIHR Doctoral Fellowship (2020-23) with Hilary Bekker (Lead S Singh, Leicester)
Joanne Butterworth (University of Exeter) – NIHR doctoral fellowship (2019-23) with Suzanne Richards (Lead J Campbell, Exeter)
Neil Corrigan – NIHR Doctoral Fellowship (2018-23) with Rebecca Walwyn
Sophie Green – University of Leeds Studentship (supported by NIHR Advanced Fellowship awarded to Dr Smith) (2021-24) with Sam Smith and Nikki Rousseau
William Goodman – ESRC WRDTP Advanced Quantitative Methods (2019-23) with Rebecca Beeken
Kate Kenny – NIHR Doctoral Fellowship (2021-24) with Robbie Foy
Arthur Lau – University of Leeds Scholarship (2017-22) with Hilary Bekker
Kelly Lloyd – White Rose DTP ESRC and Yorkshire Cancer Research Doctoral Studentship (2019-23) with Sam Smith, Lucy Ziegler, and Robbie Foy
Laura Marsden – University of Leeds and MRC (2019-22) with Rebecca Walwyn and Amanda Farrin
Current capacity building fellowships (pre- and post-doctoral awards):
Sophie Green - NIHR Development and Skills Enhancement Award (2024 - 2026)
Samuel Smith – NIHR Advanced Fellowship (2020-26)
Rebecca Walwyn – NIHR Advanced Fellowship (2022–2028)
Recently completed capacity building fellowships (pre- and post-doctoral awards):
Susanne Coleman – NIHR Development and Skills Enhancement Fellow (2021-22)
Colin Everett – NIHR Pre-Doctoral Fellowship (2020-22) with Rebecca Walwyn
Adam Grice – NIHR In-Practice Fellowship (2019-21) with Suzanne Richards and Robbie Foy
Kelly Lloyd- ESRC Post-doctoral Fellowship (2023-24) with Sam Smith and Rebecca Beeken
Kate Smith – NIHR Pre-doctoral Clinical Academic Fellowship (2021-23)
Richard Wilkins – NIHR Doctoral Fellowship (2016-21) with Rebecca Walwyn
Key Publications
Key publications
Examples of previous research by LUCID researchers:
Bryant M, Burton W, Collinson M, Martin A, Copsey B, Groves-Williams D, Foster A, Willis TA, Garnett P, O'Cathain A. Effectiveness and cost-effectiveness of a sustainable obesity prevention programme for preschool children delivered at scale ‘HENRY’ (Health, Exercise, Nutrition for the Really Young): protocol for the HENRY III cluster randomised controlled trial. BMJ Open. 2024;14(3):e081861.
Graham CD, Ellison R, Hall LH, Clark J, McNaught E, Green SMC, Wilkes H, Robson G, Lorentz I, Holmes L, Bould N, Hartley S, Naik J, Buckley S, Hirst C, Hartup S, Foy R, Neal RD, Velikova G, Farrin A, Collinson M, Smith SG. A pilot randomised controlled trial of acceptance and commitment therapy for medication decision-making and quality of life in women with breast cancer: The ACTION trial. Psychooncology. 2024 May;33(5):e6349.
Green SMC, Rousseau N, Hall LH, French DP, Graham CD, Lloyd KE, Collinson M, Ow PL, Taylor C, Howdon D, Foy R, Walwyn R, Clark J, Parbutt C, Waller J, Buxton J, Moore SJL, Velikova G, Farrin A, Smith SG. (in press) Acceptability of four intervention components supporting medication adherence in women with breast cancer: A process evaluation of a fractional factorial pilot optimization trial. Prevention Science.
Green SMC, Smith SG, Collins LM, Strayhorn JC. Decision-making in the multiphase optimization strategy (MOST): Applying decision analysis for intervention value efficiency (DAIVE) to optimize an information leaflet to promote key antecedents of medication adherence. Transl Behav Med. 2024:ibae029.
Jones G, Bailey L, Beeken RJ, Brady S, Cooper C, Copeland RJ, Crosland S, Dawson S, Faires M, Gilbody S, Haynes H, Hill A, Hillison E, Horspool M, Lee E, Li J, Machaczek KK, Parrott S, Quirk H, Stubbs B, Tew GA, Traviss-Turner G, Turton E, Walker L, Walters S, Weich S, Wildbore E, Peckham E. Supporting physical activity through co-production in people with severe mental ill health (SPACES): protocol for a randomised controlled feasibility trial. Pilot Feasibility Stud. 2024;10(1):32.
Lally P, Kennedy F, Smith S, Beeken R, Buck C, Thomas C, Counsell N, Wyld L, Martin C, Williams S, Roberts A, Greenfield D, Gath J, Potts HWW, Latimer N, Smith L, Fisher A. The feasibility and acceptability of an app-based intervention with brief behavioural support (APPROACH) to promote brisk walking in people diagnosed with breast, prostate and colorectal cancer in the UK. Cancer Med. 2024;13(6):e7124.
Murray RL, Alexandris P, Baldwin D, Brain K, Britton J, Crosbie PAJ, Gabe R, Lewis S, Parrott S, Quaife SL, Tam HZ, Wu Q, Beeken R, Copeland H, Eckert C, Hancock N, Lindop J, McCutchan G, Marshall C, Neal RD, Rogerson S, Quinn Scoggins HD, Simmonds I, Thorley R, Callister ME. Uptake and 4-week quit rates from an opt-out co-located smoking cessation service delivered alongside community-based low-dose computed tomography screening within the Yorkshire Lung Screening Trial. Eur Respir J. 2024;63(4):2301768.
Surr C, Marsden L, Griffiths A, Cox S, Fossey J, Martin A, Prevost AT, Walshe C, Walwyn R. Researchers’ experiences of the design and conduct challenges associated with parallel-group cluster-randomised trials and views on a novel open-cohort design. PLoS One. 2024;19(2):e0297184.
Alderson S, Ivers NM, Foy R. The opioid prescribing problem: an opportunity to embed rigorous evaluation within initiatives to improve population healthcare. BMJ Qual Saf. 2023;32(11):617-619.
Brown JE, Royle KL, Gregory W, Ralph C, Maraveyas A, Din O, Eisen T, Nathan P, Powles T, Griffiths R, Jones R, Vasudev N, Wheater M, Hamid A, Waddell T, McMenemin R, Patel P, Larkin J, Faust G, Martin A, et al. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. Lancet Oncol. 2023;24(3):213-27.
Foy R, Ivers NM, Grimshaw JM, Wilson PM. What is the role of randomised trials in implementation science? Trials. 2023;24(1):537.
Green SMC, French DP, Hall LH, Bartlett YK, Rousseau N, Raine E, Parbutt C, Gardner B; ROSETA Investigators; Smith SG. Co-development of a Text Messaging Intervention to Support Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: Mixed Methods Approach. J Med Internet Res. 2023;25:e38073.
Green SMC, Hall LH, French DP, Rousseau N, Parbutt N, Walwyn R, Smith SG. Optimization of an information leaflet to support medication beliefs in women with breast cancer: a randomized factorial experiment. Ann Behav Med. 2023;57(11):988-1000.
Green SMC, Hall LH, Rousseau N, French DP, Graham CD, Collinson M, Mason E, Wilkes H, McNaught E, Howdon D, Foy R, Waller J, Walwyn R, Clark J, Parbutt C, Raine E, Ellison R, Buxton J, Hartley S, Moore SJL, Velikova G, Farrin A, Smith SG. Acceptability, fidelity and trial experience of four intervention components to support medication adherence in women with breast cancer: A process evaluation protocol for a pilot fractional factorial trial [version 2; peer review: 2 approved]. NIHR Open Res. 2023;3:3.
Munro J, Goodman W, Oliphant R, Russell S, Taylor C, Beeken RJ, Hubbard G. Hernia Active Living Trial (HALT): a feasibility study of a physical activity intervention for people with a bowel stoma who have a parastomal hernia/bulge. Pilot Feasibility Stud. 2023;9(1):111.
Peckham E, Tew G, Lorimer B, Bailey L, Beeken R, Cooper C, Gascoyne S, Gilbody S, Jones G, Machaczek K, Pickering K, Traviss-Turner G, Stubbs B. Interventions to increase physical activity and reduce sedentary behaviour in severe mental ill health: How effective are they?’- A systematic review. Mental Health and Physical Activity. 2023;25:100547-100547
Pini S, Goodman W, Raby E, McGinley C, Perez-Cornago A, Johnson F, Beeken RJ. Development and initial qualitative evaluation of a novel school-based nutrition intervention - COOKKIT (Cooking Kit for Kids). BMC Public Health. 2023;23(1):1742.
Smith SG, Green SMC, Ellison R, Foy R, Graham CD, Mason E, French DP, Hall LH, Wilkes H, McNaught E, Raine E, Walwyn R, Howdon D, Clark J, Rousseau N, Buxton J, Moore SJL, Parbutt C, Velikova G, Farrin A, Collinson M. Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: protocol for a pilot fractional factorial trial. BMJ Open. 2023;13(2):e069971.
Tew GA, Bailey L, Beeken RJ, Cooper C, Copeland R, Brady S, Heron P, Hill A, Lee E, Spanakis P, Stubbs B, Traviss-Turner G, Walker L, Walters S, Gilbody S, Peckham E. Physical Activity in Adults with Schizophrenia and Bipolar Disorder: A Large Cross-Sectional Survey Exploring Patterns, Preferences, Barriers, and Motivating Factors. 2023;20(3):2548.
Ahmed S, Airlie J, Clegg A, Copsey B, Cundill B, Forster A, Heaven A, Johansson JF, Kime N, Moreau L, Ozer S, Parker C, Richards SH, Thompson E, Farrin AJ. A new opportunity for enhancing trial efficiency: Can we investigate intervention implementation processes within trials using SWAT (study within a trial) methodology? Research Methods in Medicine and Health Sciences. 2022;3(3):66-73.
Glidewell L, Hunter C, Ward V, McEachan RRC, Lawton R, Willis TA, Hartley S, Collinson M, Holland M, Farrin AJ, Foy R. Explaining variable effects of an adaptable implementation package to promote evidence-based practice in primary care: a longitudinal process evaluation. Implement Sci. 2022;17(1):9.
Green SMC, French DP, Graham CD, Hall LH, Rousseau N, Foy R, Clark J, Parbutt C, Raine E, Gardner B, Velikova G, Moore SJL, Buxton J; ROSETA investigators; Smith SG. Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy. BMC Health Serv Res. 2022;22(1):1081.
Higham R, Pini S, Quyn A, Kowal M, Helliwell J, Saman R, Lewthwaite P, Young N, Rousseau N. Rapid qualitative analysis in a mixed-methods evaluation of an infection prevention intervention in a UK hospital setting during the COVID-19 pandemic: A discussion of the CLEAN study methodology. Front Sociol. 2022;7:958250.
Hunot-Alexander C, Croker H, Fildes A, Johnson F, Beeken RJ. Brief ‘Appetitive Trait Tailored Intervention’: Development in a Sample of Adults with Overweight and Obesity. Behaviour Change. 2022;39(2):106-22.
Lally P, Beeken RJ, Wilson R, Omar R, Hunter R, Fovargue S, Anderson D, King M, Hassiotis A, Croker H. A manualised weight management programme for adults with mild-moderate intellectual disabilities affected by excess weight: A randomised controlled feasibility trial (Shape Up-LD). J Appl Res Intellect Disabil. 2022;35(1):112-22.
Shepherd V, Wood F, Gillies K, O'Connell A, Martin A, Hood K. Recruitment interventions for trials involving adults lacking capacity to consent: methodological and ethical considerations for designing Studies Within a Trial (SWATs). Trials. 2022;23(1):756.
Siddle HJ, Chapman LS, Mankia K, Zăbălan C, Kouloumas M, Raza K, Falahee M, Kerry J, Kerschbaumer A, Aletaha D, Emery P, Richards SH. Perceptions and experiences of individuals at-risk of rheumatoid arthritis (RA) knowing about their risk of developing RA and being offered preventive treatment: systematic review and thematic synthesis of qualitative studies. Ann Rheum Dis. 2022;81(2):159-68.
Stanworth SJ, Walwyn R, Grant-Casey J, Hartley S, Moreau L, Lorencatto F, Francis J, Gould N, Swart N, Rowley M, Morris S, Grimshaw J, Farrin A, Foy R. Effectiveness of Enhanced Performance Feedback on Appropriate Use of Blood Transfusions: A Comparison of 2 Cluster Randomized Trials. JAMA Netw Open. 2022;5(2):e220364.
Wright-Hughes A, Willis TA, Wilson S, Weller A, Lorencatto F, Althaf M, Seymour V, Farrin AJ, Francis J, Brehaut J, Ivers N, Alderson SL, Brown BC, Feltbower RG, Gale CP, Stanworth SJ, Hartley S, Colquhoun H, Presseau J, Walwyn R, Foy R. A randomised fractional factorial screening experiment to predict effective features of audit and feedback. Implement Sci. 2022;17(1):34.
Alderson SL, Farragher TM, Willis TA, Carder P, Johnson S, Foy R. The effects of an evidence- and theory-informed feedback intervention on opioid prescribing for non-cancer pain in primary care: A controlled interrupted time series analysis. PLoS Med. 2021;18(10):e1003796.
Bonner RJ, Wallace T, Jones AD, Julian Scott D, Richards SH. The Content of Pre-habilitative Interventions for Patients Undergoing Repair of Abdominal Aortic Aneurysms and Their Effect on Post-Operative Outcomes: A Systematic Review. Eur J Vasc Endovasc Surg. 2021;61(5):756-65.
Bryant M, Burton W, Collinson M, Farrin A, Nixon J, Stevens J, Roberts K, Foy R, Rutter H, Copsey B, Hartley S, Tubeuf S, Brown J. A cluster RCT and process evaluation of an implementation optimisation intervention to promote parental engagement enrolment and attendance in a childhood obesity prevention programme: results of the Optimising Family Engagement in HENRY (OFTEN) trial. Trials. 2021;22(1):773.
Gardner B, Richards R, Lally P, Rebar A, Thwaite T, Beeken RJ. Breaking habits or breaking habitual behaviours? Old habits as a neglected factor in weight loss maintenance. Appetite. 2021;162:105183.
Soni A, Beeken RJ, McGowan L, Lawson V, Chadwick P, Croker H. 'Shape-Up', a Modified Cognitive-Behavioural Community Programme for Weight Management: Real-World Evaluation as an Approach for Delivering Public Health Goals. Nutrients. 2021;13(8).
Surr CA, Holloway I, Walwyn REA, Griffiths AW, Meads D, Martin A, Kelley R, Ballard C, Fossey J, Burnley N, Chenoweth L, Creese B, Downs M, Garrod L, Graham EH, Lilley-Kelly A, McDermid J, McLellan V, Millard H, Perfect D, Robinson L, Robinson O, Shoesmith E, Siddiqi N, Stokes G, Wallace D, Farrin AJ. Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trial. Aging Ment Health. 2021;25(8):1410-23.
Wood S, Foy R, Willis TA, Carder P, Johnson S, Alderson S. General practice responses to opioid prescribing feedback: a qualitative process evaluation. Br J Gen Pract. 2021;71(711):e788-e96.
Butterworth J, Richards S, Warren F, Pitchforth E, Campbell J. Randomised feasibility trial and embedded qualitative process evaluation of a new intervention to facilitate the involvement of older patients with multimorbidity in decision-making about their healthcare during general practice consultations: the VOLITION study protocol. Pilot Feasibility Stud. 2020;6:161.
Butterworth JE, Hays R, McDonagh STJ, Bower P, Pitchforth E, Richards SH, Campbell JL. Involving older people with multimorbidity in decision-making about their primary healthcare: A Cochrane systematic review of interventions (abridged). Patient Educ Couns. 2020;103(10):2078-94.
Galloway AM, van-Hille T, Perry DC, Holton C, Mason L, Richards S, Siddle HJ, Comer C. A systematic review of the non-surgical treatment of Perthes' disease. Bone Jt Open. 2020;1(12):720-30.
Hubbard G, Taylor C, Watson AJM, Munro J, Goodman W, Beeken RJ. A physical activity intervention to improve the quality of life of patients with a stoma: a feasibility study. Pilot Feasibility Stud. 2020;6:12.
Koutoukidis DA, Land J, Hackshaw A, Heinrich M, McCourt O, Beeken RJ, Philpott S, DeSilva D, Rismani A, Rabin N, Popat R, Kyriakou C, Papanikolaou X, Mehta A, Paton B, Fisher A, Yong KL. Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design. Br J Cancer. 2020;123(2):187-95.
Land J, McCourt O, Heinrich M, Beeken RJ, Koutoukidis DA, Paton B, Yong K, Hackshaw A, Fisher A. The adapted Zelen was a feasible design to trial exercise in myeloma survivors. J Clin Epidemiol. 2020;125:76-83.
Meads DM, Martin A, Griffiths A, Kelley R, Creese B, Robinson L, McDermid J, Walwyn R, Ballard C, Surr CA. Cost-Effectiveness of Dementia Care Mapping in Care-Home Settings: Evaluation of a Randomised Controlled Trial. Appl Health Econ Health Policy. 2020;18(2):237-47.
Quaife SL, Ruparel M, Dickson JL, Beeken RJ, McEwen A, Baldwin DR, Bhowmik A, Navani N, Sennett K, Duffy SW, Wardle J, Waller J, Janes SM. Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials. Am J Respir Crit Care Med. 2020;201(8):965-75.
Ski CF, Taylor RS, McGuigan K, Lambert JD, Richards SH, Thompson DR. Psychological interventions for depression and anxiety in patients with coronary heart disease, heart failure or atrial fibrillation. Cochrane Database Syst Rev. 2020(7):CD013508.
Butterworth JE, Hays R, McDonagh ST, Richards SH, Bower P, Campbell J. Interventions for involving older patients with multi-morbidity in decision-making during primary care consultations. Cochrane Database Syst Rev. 2019;2019(10):CD013124.
Caperon L, Arjyal A, K CP, Kuikel J, Newell J, Peters R, Prestwich A, King R. Developing a socio-ecological model of dietary behaviour for people living with diabetes or high blood glucose levels in urban Nepal: A qualitative investigation. PLoS One. 2019;14(3):e0214142.
Kliemann N, Croker H, Johnson F, Beeken RJ. Development of the Top Tips Habit-Based Weight Loss App and Preliminary Indications of Its Usage, Effectiveness, and Acceptability: Mixed-Methods Pilot Study. JMIR Mhealth Uhealth. 2019;7(5):e12326.
O'Cathain A, Croot L, Duncan E, Rousseau N, Sworn K, Turner KM, Yardley L, Hoddinott P. Guidance on how to develop complex interventions to improve health and healthcare. BMJ Open. 2019;9(8):e029954.
O'Cathain A, Croot L, Sworn K, Duncan E, Rousseau N, Turner K, Yardley L, Hoddinott P. Taxonomy of approaches to developing interventions to improve health: a systematic methods overview. Pilot Feasibility Stud. 2019;5:41.
Rousseau N, Turner KM, Duncan E, O'Cathain A, Croot L, Yardley L, Hoddinott P. Attending to design when developing complex health interventions: A qualitative interview study with intervention developers and associated stakeholders. PLoS One. 2019;14(10):e0223615.
Turner KM, Rousseau N, Croot L, Duncan E, Yardley L, O'Cathain A, Hoddinott P. Understanding successful development of complex health and healthcare interventions and its drivers from the perspective of developers and wider stakeholders: an international qualitative interview study. BMJ Open. 2019;9(5):e028756.
Koutoukidis DA, Lopes S, Atkins L, Croker H, Knobf MT, Lanceley A, Beeken RJ. Use of intervention mapping to adapt a health behavior change intervention for endometrial cancer survivors: the shape-up following cancer treatment program. BMC Public Health. 2018;18(1):415.
Mahmoodi N, Bekker HL, King NV, Hughes J, Jones GL. Are publicly available internet resources enabling women to make informed fertility preservation decisions before starting cancer treatment: an environmental scan? BMC Med Inform Decis Mak. 2018;18(1):104.
Richards SH, Dickens C, Anderson R, Richards DA, Taylor RS, Ukoumunne OC, Turner KM, Gandhi M, Kuyken W, Gibson A, Davey A, Warren F, Winder R, Campbell J. Assessing the effectiveness of Enhanced Psychological Care for patients with depressive symptoms attending cardiac rehabilitation compared with treatment as usual (CADENCE): a pilot cluster randomised controlled trial. Trials. 2018;19(1):211.
Sepucha KR, Abhyankar P, Hoffman AS, Bekker HL, LeBlanc A, Levin CA, Ropka M, Shaffer VA, Sheridan SL, Stacey D, Stalmeier P, Vo H, Wills CE, Thomson R. Standards for UNiversal reporting of patient Decision Aid Evaluation studies: the development of SUNDAE Checklist. BMJ Qual Saf. 2018;27(5):380-8.
Bennett MI, Mulvey MR, Campling N, Latter S, Richardson A, Bekker H, Blenkinsopp A, Carder P, Closs J, Farrin A, Flemming K, Gallagher J, Meads D, Morley S, O'Dwyer J, Wright-Hughes A, Hartley S. Self-management toolkit and delivery strategy for end-of-life pain: the mixed-methods feasibility study. Health Technol Assess. 2017;21(76):1-292.
Freeman M, Offman J, Walter FM, Sasieni P, Smith SG. Acceptability of the Cytosponge procedure for detecting Barrett's oesophagus: a qualitative study. BMJ Open. 2017;7(3):e013901.
Khanal S, Elsey H, King R, Baral SC, Bhatta BR, Newell JN. Development of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal. PLoS One. 2017;12(1):e0167559.
Kliemann N, Vickerstaff V, Croker H, Johnson F, Nazareth I, Beeken RJ. The role of self-regulatory skills and automaticity on the effectiveness of a brief weight loss habit-based intervention: secondary analysis of the 10 top tips randomised trial. Int J Behav Nutr Phys Act. 2017;14(1):119.
Turner KM, Winder R, Campbell JL, Richards DA, Gandhi M, Dickens CM, Richards S. Patients' and nurses' views on providing psychological support within cardiac rehabilitation programmes: a qualitative study. BMJ Open. 2017;7(9):e017510.
Coleman S, Nixon J, Keen J, Muir D, Wilson L, McGinnis E, Stubbs N, Dealey C, Nelson EA. Using cognitive pre-testing methods in the development of a new evidenced-based pressure ulcer risk assessment instrument. BMC Med Res Methodol. 2016;16(1):158.
Lorencatto F, Gould NJ, McIntyre SA, During C, Bird J, Walwyn R, Cicero R, Glidewell L, Hartley S, Stanworth SJ, Foy R, Grimshaw JM, Michie S, Francis JJ. A multidimensional approach to assessing intervention fidelity in a process evaluation of audit and feedback interventions to reduce unnecessary blood transfusions: a study protocol. Implement Sci. 2016;11(1):163.
McEachan RRC, Santorelli G, Bryant M, Sahota P, Farrar D, Small N, Akhtar S, Sargent J, Barber SE, Taylor N, Richardson G, Farrin AJ, Bhopal RS, Bingham DD, Ahern SM, Wright J. The HAPPY (Healthy and Active Parenting Programmme for early Years) feasibility randomised control trial: acceptability and feasibility of an intervention to reduce infant obesity. BMC Public Health. 2016;16:211.
Winterbottom AE, Gavaruzzi T, Mooney A, Wilkie M, Davies SJ, Crane D, Tupling K, Baxter PD, Meads DM, Mathers N, Bekker HL. Patient Acceptability of the Yorkshire Dialysis Decision Aid (YoDDA) Booklet: A Prospective Non-Randomized Comparison Study Across 6 Predialysis Services. Perit Dial Int. 2016;36(4):374-81.
Wright J, Fairley L, McEachan R, Bryant M, Petherick E, Sahota P, Santorelli G, Barber S, Lawlor DA, Taylor N, Bhopal R, Cameron N, West J, Hill A, Summerbell C, Farrin A, Ball H, Brown T, Farrar D, Small N. Programme Grants for Applied Research. Development and evaluation of an intervention for the prevention of childhood obesity in a multiethnic population: the Born in Bradford applied research programme. 2016. Southampton (UK): NIHR Journals Library
Backman R, Foy R, Michael BD, Defres S, Kneen R, Solomon T. The development of an intervention to promote adherence to national guidelines for suspected viral encephalitis. Implement Sci. 2015;10:37.
Smith SG, Raine R, Obichere A, Wolf MS, Wardle J, von Wagner C. The effect of a supplementary ('Gist-based') information leaflet on colorectal cancer knowledge and screening intention: a randomized controlled trial. J Behav Med. 2015;38(2):261-72.
Coleman S, Nixon J, Keen J, Wilson L, McGinnis E, Dealey C, Stubbs N, Farrin A, Dowding D, Schols JM, Cuddigan J, Berlowitz D, Jude E, Vowden P, Schoonhoven L, Bader DL, Gefen A, Oomens CW, Nelson EA. A new pressure ulcer conceptual framework. J Adv Nurs. 2014;70(10):2222-34.
Coleman S, Gorecki C, Nelson EA, Closs SJ, Defloor T, Halfens R, Farrin A, Brown J, Schoonhoven L, Nixon J. Patient risk factors for pressure ulcer development: systematic review. Int J Nurs Stud. 2013;50(7):974-1003.
Grant A, Treweek S, Dreischulte T, Foy R, Guthrie B. Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting. Trials. 2013;14:15.
Smith SG, Wolf MS, Obichere A, Raine R, Wardle J, von Wagner C. The development and testing of a brief ('gist-based') supplementary colorectal cancer screening information leaflet. Patient Educ Couns. 2013;93(3):619-25.